Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Claudia Rauh"'
Autor:
Carmen Joder, Celine Smaadahl-Wey, Lara Zumwald, Flurina Saner, Claudia Rauh, Seline Hofer, Julian Wampfler, Saskia Schlootz, Tilman Rau, Lucine Christe, Wiebke Solass, Sara Imboden, Michael David Mueller, Franziska Siegenthaler
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionCentralization of ovarian cancer treatment is associated with higher rates of optimal surgery and longer survival. However, preoperative diagnosis of ovarian cancer is challenging and some diagnoses are made incidentally after surgery. Th
Externí odkaz:
https://doaj.org/article/901442caa23c49f8971c7d7f47a56bdd
Autor:
Markus Wallwiener, Naiba Nabieva, Manuel Feisst, Tanja Fehm, Johann de Waal, Mahdi Rezai, Bernd Baier, Gerold Baake, Hans-Christian Kolberg, Martin Guggenberger, Mathias Warm, Nadia Harbeck, Rachel Wuerstlein, Jörg-Uwe Deuker, Peter Dall, Barbara Richter, Grischa Wachsmann, Cosima Brucker, Jan Willem Siebers, Milos Popovic, Thomas Kuhn, Christopher Wolf, Hans-Walter Vollert, Georg-Peter Breitbach, Wolfgang Janni, Robert Landthaler, Andreas Kohls, Daniela Rezek, Thomas Noesselt, Gunnar Fischer, Stephan Henschen, Thomas Praetz, Volker Heyl, Thorsten Kühn, Thomas Krauss, Christoph Thomssen, Andre Hohn, Hans Tesch, Christoph Mundhenke, Alexander Hein, Claudia Rauh, Christian M. Bayer, Katja Schmidt, Erik Belleville, Sara Y. Brucker, Peyman Hadji, Matthias W. Beckmann, Diethelm Wallwiener, Sherko Kümmel, Andreas Hartkopf, Peter A. Fasching
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Treatment of postmenopausal, hormone receptor-positive metastatic breast cancer (MBC) patients varies despite clear therapy guidelines, favoring endocrine treatment (ET). Aim of this study was to analyze persistence of palliative
Externí odkaz:
https://doaj.org/article/288dc4797ece43779ee02ebaad868ad3
Autor:
Paul Gass, Michael P. Lux, Claudia Rauh, Alexander Hein, Mayada R. Bani, Cornelia Fiessler, Arndt Hartmann, Lothar Häberle, Jutta Pretscher, Ramona Erber, David L. Wachter, Rüdiger Schulz-Wendtland, Matthias W. Beckmann, Peter A. Fasching, Marius Wunderle
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates predictors of the res
Externí odkaz:
https://doaj.org/article/27207d1303ab4a1fa4d061a8ebdcbf30
Autor:
Hanna Huebner, Peter A. Fasching, Walter Gumbrecht, Sebastian Jud, Claudia Rauh, Mark Matzas, Peter Paulicka, Katja Friedrich, Michael P. Lux, Bernhard Volz, Paul Gass, Lothar Häberle, Franziska Meier-Stiegen, Andreas Hartkopf, Hans Neubauer, Katrin Almstedt, Matthias W. Beckmann, Tanja N. Fehm, Matthias Ruebner
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background The assessment of circulating tumor cells (CTCs) has been shown to enable monitoring of treatment response and early detection of metastatic breast cancer (MBC) recurrence. The aim of this study was to compare a well-established C
Externí odkaz:
https://doaj.org/article/bfd317d8ccf64d408ee42d08b0da35cb
Autor:
Carolin C. Hack MD, Peter A. Fasching MD, Tanja Fehm MD, Johann de Waal MD, Mahdi Rezai MD, Bernd Baier MD, Gerold Baake MD, Hans-Christian Kolberg MD, Martin Guggenberger MD, Mathias Warm MD, Nadia Harbeck MD, Rachel Wuerstlein MD, Jörg-Uwe Deuker MD, Peter Dall MD, Barbara Richter MD, Grischa Wachsmann MD, Cosima Brucker MD, Jan W. Siebers MD, Nikos Fersis MD, Thomas Kuhn MD, Christopher Wolf MD, Hans-Walter Vollert MD, Georg-Peter Breitbach MD, Wolfgang Janni MD, Robert Landthaler MD, Andreas Kohls MD, Daniela Rezek MD, Thomas Noesslet MD, Gunnar Fischer MD, Stefan Henschen MD, Thomas Praetz MD, Volker Heyl MD, Thorsten Kühn MD, Thomas Krauss MD, Christoph Thomssen MD, Andre Hohn MD, Hans Tesch MD, Christoph Mundhenke MD, Alexander Hein MD, Claudia Rauh MD, Christian M. Bayer MD, Adib Jacob, Katja Schmidt PhD, Erik Belleville PhD, Peyman Hadji MD, Sara Y. Brucker MD, Diethelm Wallwiener MD, Sherko Kümmel MD, Matthias W. Beckmann MD, Daniela Paepke MD
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
Background . Breast cancer patients often use complementary and alternative medicine, but few prospectively collected data on the topic are available specifically for postmenopausal breast cancer patients. A large prospective study was therefore cond
Externí odkaz:
https://doaj.org/article/d2a81d21043643fba118f1259ec81715
Autor:
Michael G Schrauder, Reiner Strick, Rüdiger Schulz-Wendtland, Pamela L Strissel, Laura Kahmann, Christian R Loehberg, Michael P Lux, Sebastian M Jud, Arndt Hartmann, Alexander Hein, Christian M Bayer, Mayada R Bani, Swetlana Richter, Boris R Adamietz, Evelyn Wenkel, Claudia Rauh, Matthias W Beckmann, Peter A Fasching
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e29770 (2012)
IntroductionMicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules with relevance as regulators of gene expression thereby affecting crucial processes in cancer development. MiRNAs offer great potential as biomarkers for cancer detec
Externí odkaz:
https://doaj.org/article/7ffd56597d53499ebe1fe670980c7936
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Autor:
Heiko Graf, Bernhard Volz, Matthias W. Beckmann, Bernhard Martin, Christian M. Bayer, Achim Rody, Alexander Fridman, Christoph Thomssen, CB Walter, Andreas D. Hartkopf, Tanja Fehm, Felix Heindl, Rachel Wuerstlein, Volker Schulz, Sara Y. Brucker, Brigitte Rack, Peter A. Fasching, Christian R. Loehberg, Dieter Steinfeld-Birg, Tobias Brodkorb, Hans-Christian Kolberg, Wolfram Malter, Katrin Almstedt, Carolin C. Hack, Lothar Häberle, G. Baake, Petra Krabisch, Nicolai Maass, Sherko Kuemmel, Volker Pelzer, Christoph Lindner, Paul Gass, C. Wolf, Michael Weigel, A. Kohls, Michael P. Lux, Claudia Rauh, C Brucker, Oliver Hoffmann, Wolfgang Janni, Naiba Nabieva, Nadia Harbeck, Alexander Hein, G. Fischer
Publikováno v:
International Journal of Cancer. 145:2114-2121
One of the most common adverse events (AEs) occurring during treatment with aromatase inhibitors (AIs) is musculoskeletal pain. The aim of our study was to analyze the influence of preexisting muscle/limb pain and joint pain on the development of AI-
Autor:
Michael M. Lux, M. W. Beckmann, Michael Schneider, Felix Heindl, Sebastian M. Jud, Eva Balbach, Ramona Erber, Arndt Hartmann, Marius Wunderle, Rüdiger Schulz-Wendtland, Claudia Rauh, Anna-Lisa Brandl, Carolin C. Hack
Publikováno v:
Frauenheilkunde up2date. 13:39-57